Partial Inhibition of mTORC1 in Aged Rats Counteracts the Decline in Muscle Mass and Reverses Molecular Signaling Associated with Sarcopenia

REFERENCES

• Egerman MA, Glass DJ. 2014. Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol 49:59–68. https://doi.org/10.3109/10409238.2013.857291.
   PubMed Web of Science ®Google Scholar
• Glass D, Roubenoff R. 2010. Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci 1211:25–36. https://doi.org/10.1111/j.1749-6632.2010.05809.x.
   PubMed Web of Science ®Google Scholar
• Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J. 2011. Gait speed and survival in older adults. JAMA 305:50–58. https://doi.org/10.1001/jama.2010.1923.
   PubMed Web of Science ®Google Scholar
• Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD; Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. 2011. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12:403–409. https://doi.org/10.1016/j.jamda.2011.04.014.
   PubMed Web of Science ®Google Scholar
• Armanios M, de Cabo R, Mannick J, Partridge L, van Deursen J, Villeda S. 2015. Translational strategies in aging and age-related disease. Nat Med 21:1395–1399. https://doi.org/10.1038/nm.4004.
   PubMedGoogle Scholar
• Niccoli T, Partridge L. 2012. Ageing as a risk factor for disease. Curr Biol 22:R741–R752. https://doi.org/10.1016/j.cub.2012.07.024.
   PubMed Web of Science ®Google Scholar
• Kenyon CJ. 2010. The genetics of ageing. Nature 464:504–512. https://doi.org/10.1038/nature08980.
   PubMed Web of Science ®Google Scholar
• Hofmann JW, Zhao X, De Cecco M, Peterson AL, Pagliaroli L, Manivannan J, Hubbard GB, Ikeno Y, Zhang Y, Feng B, Li X, Serre T, Qi W, Van Remmen H, Miller RA, Bath KG, de Cabo R, Xu H, Neretti N, Sedivy JM. 2015. Reduced expression of MYC increases longevity and enhances healthspan. Cell 160:477–488. https://doi.org/10.1016/j.cell.2014.12.016.
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Liu Y, Zheng P. 2009. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2:ra75. https://doi.org/10.1126/scisignal.2000559.
   PubMed Web of Science ®Google Scholar
• Flynn JM, O'Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, Zykovich A, Mooney SD, Strong R, Rosen CJ, Kapahi P, Nelson MD, Kennedy BK, Melov S. 2013. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 12:851–862. https://doi.org/10.1111/acel.12109.
   PubMed Web of Science ®Google Scholar
• Johnson SC, Rabinovitch PS, Kaeberlein M. 2013. mTOR is a key modulator of ageing and age-related disease. Nature 493:338–345. https://doi.org/10.1038/nature11861.
   PubMed Web of Science ®Google Scholar
• Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA. 2009. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395. https://doi.org/10.1038/nature08221.
   PubMed Web of Science ®Google Scholar
• Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R. 2011. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66:191–201. https://doi.org/10.1093/gerona/glq178.
   PubMed Web of Science ®Google Scholar
• Miller RA, Harrison DE, Astle CM, Fernandez E, Flurkey K, Han M, Javors MA, Li X, Nadon NL, Nelson JF, Pletcher S, Salmon AB, Sharp ZD, Van Roekel S, Winkleman L, Strong R. 2014. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 13:468–477. https://doi.org/10.1111/acel.12194.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bokov A, Gelfond J, Soto V, Ikeno Y, Hubbard G, Diaz V, Sloane L, Maslin K, Treaster S, Rendon S, van Remmen H, Ward W, Javors M, Richardson A, Austad SN, Fischer K. 2014. Rapamycin extends life and health in C57BL/6 mice. J Gerontol A Biol Sci Med Sci 69:119–130. https://doi.org/10.1093/gerona/glt056.
   PubMedGoogle Scholar
• Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, Lonetto MA, Maecker HT, Kovarik J, Carson S, Glass DJ, Klickstein LB. 2014. mTOR inhibition improves immune function in the elderly. Sci Transl Med 6:268ra179. https://doi.org/10.1126/scitranslmed.3009892.
   PubMed Web of Science ®Google Scholar
• Shavlakadze T, Zhu J, Wang S, Zhou W, Morin B, Egerman MA, Fan L, Wang Y, Iartchouk O, Meyer A, Valdez RA, Mannick JB, Klickstein LB, Glass DJ. 2018. Short-term low-dose mTORC1 inhibition in aged rats counter-regulates age-related gene changes and blocks age-related kidney pathology. J Gerontol A Biol Sci Med Sci 73:845–852. https://doi.org/10.1093/gerona/glx249.
   PubMedGoogle Scholar
• Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, John C, Lawrence JC, David J, Glass DJ, Yancopoulos GD. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014–1013. https://doi.org/10.1038/ncb1101-1014.
   PubMed Web of Science ®Google Scholar
• Choi DH, Yang J, Kim YS. 2019. Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway. Biochem Biophys Rep 17:182–190. https://doi.org/10.1016/j.bbrep.2018.12.009.
   PubMedGoogle Scholar
• Yoon M-S. 2017. mTOR as a key regulator in maintaining skeletal muscle mass. Front Physiol 8:788–788. https://doi.org/10.3389/fphys.2017.00788.
   PubMed Web of Science ®Google Scholar
• Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009–1013. https://doi.org/10.1038/ncb1101-1009.
   PubMed Web of Science ®Google Scholar
• Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. 2002. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163–175. https://doi.org/10.1016/S0092-8674(02)00808-5.
   PubMed Web of Science ®Google Scholar
• Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM. 2006. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11:859–871. https://doi.org/10.1016/j.devcel.2006.10.007.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex. Science 307:1098–1101. https://doi.org/10.1126/science.1106148.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Sabatini DM. 2005. Redox regulation of the nutrient-sensitive Raptor-mTOR pathway and complex. J Biol Chem 280:39505–39509. https://doi.org/10.1074/jbc.M506096200.
   PubMed Web of Science ®Google Scholar
• Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL. 2007. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metabolism 6:472–483. https://doi.org/10.1016/j.cmet.2007.11.004.
   PubMed Web of Science ®Google Scholar
• Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S, Sandri M. 2007. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6:458–471. https://doi.org/10.1016/j.cmet.2007.11.001.
   PubMed Web of Science ®Google Scholar
• McLoughlin TJ, Smith SM, DeLong AD, Wang H, Unterman TG, Esser KA. 24 June 2009, posting date. FoxO1 induces apoptosis in skeletal myotubes in a DNA binding-dependent manner. Am J Physiol Cell Physiol. https://doi.org/10.1152/ajpcell.00502.2008.
   Google Scholar
• Southgate RJ, Neill B, Prelovsek O, El-Osta A, Kamei Y, Miura S, Ezaki O, McLoughlin TJ, Zhang W, Unterman TG, Febbraio MA. 2007. FOXO1 Regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J Biol Chem 282:21176–21186. https://doi.org/10.1074/jbc.M702039200.
   PubMedGoogle Scholar
• Rüegg MA, Glass DJ. 2011. Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol 51:373–395. https://doi.org/10.1146/annurev-pharmtox-010510-100537.
   PubMed Web of Science ®Google Scholar
• Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399–412. https://doi.org/10.1016/s0092-8674(04)00400-3.
   PubMed Web of Science ®Google Scholar
• Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395–403. https://doi.org/10.1016/S1097-2765(04)00211-4.
   PubMed Web of Science ®Google Scholar
• Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704–1708. https://doi.org/10.1126/science.1065874.
   PubMed Web of Science ®Google Scholar
• Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. 2001. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98:14440–14445. https://doi.org/10.1073/pnas.251541198.
   PubMed Web of Science ®Google Scholar
• Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E, Glass DJ. 2007. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 6:376–385. https://doi.org/10.1016/j.cmet.2007.09.009.
   PubMed Web of Science ®Google Scholar
• Tintignac LA, Lagirand J, Batonnet S, Sirri V, Leibovitch MP, Leibovitch SA. 5 November 2004, posting date. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem. https://doi.org/10.1074/jbc.M411346200.
   Google Scholar
• Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL. 2009. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185:1083–1095. https://doi.org/10.1083/jcb.200901052.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan K-L. 2011. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132–141. https://doi.org/10.1038/ncb2152.
   PubMed Web of Science ®Google Scholar
• Milan G, Romanello V, Pescatore F, Armani A, Paik J-H, Frasson L, Seydel A, Zhao J, Abraham R, Goldberg AL, Blaauw B, DePinho RA, Sandri M. 2015. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun 6:6670–6670. https://doi.org/10.1038/ncomms7670.
   PubMed Web of Science ®Google Scholar
• Cuervo AM. 2008. Autophagy and aging: keeping that old broom working. Trends Genet 24:604–612. https://doi.org/10.1016/j.tig.2008.10.002.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Mariño G, Kroemer G. 2011. Autophagy and aging. Cell 146:682–695. https://doi.org/10.1016/j.cell.2011.07.030.
   PubMed Web of Science ®Google Scholar
• Demontis F, Perrimon N. 2010. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell 143:813–825. https://doi.org/10.1016/j.cell.2010.10.007.
   PubMed Web of Science ®Google Scholar
• Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M. 2009. Autophagy is required to maintain muscle mass. Cell Metab 10:507–515. https://doi.org/10.1016/j.cmet.2009.10.008.
   PubMed Web of Science ®Google Scholar
• Sengupta P. 2013. The laboratory rat: relating its age with human's. Int J Prev Med 4:624–630.
   PubMedGoogle Scholar
• Lamming DW, Ye L, Sabatini DM, Baur JA. 2013. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest 123:980–989. https://doi.org/10.1172/JCI64099.
   PubMed Web of Science ®Google Scholar
• Ibebunjo C, Chick JM, Kendall T, Eash JK, Li C, Zhang Y, Vickers C, Wu Z, Clarke BA, Shi J, Cruz J, Fournier B, Brachat S, Gutzwiller S, Ma Q, Markovits J, Broome M, Steinkrauss M, Skuba E, Galarneau JR, Gygi SP, Glass DJ. 2013. Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia. Mol Cell Biol 33:194–212. https://doi.org/10.1128/MCB.01036-12.
   PubMed Web of Science ®Google Scholar
• Castets P, Lin S, Rion N, Di Fulvio S, Romanino K, Guridi M, Frank S, Tintignac LA, Sinnreich M, Rüegg MA. 2013. Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab 17:731–744. https://doi.org/10.1016/j.cmet.2013.03.015.
   PubMed Web of Science ®Google Scholar
• Summermatter S, Bouzan A, Pierrel E, Melly S, Stauffer D, Gutzwiller S, Nolin E, Dornelas C, Fryer C, Leighton-Davies J, Glass DJ, Fournier B. 1 March 2017, posting date. Blockade of metallothioneins 1 and 2 increases skeletal muscle mass and strength. Mol Cell Biol. https://doi.org/10.1128/MCB.00305-16.
   Google Scholar
• Sousa-Victor P, Gutarra S, García-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V, Jardí M, Ballestar E, González S, Serrano AL, Perdiguero E, Muñoz-Cánoves P. 2014. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 506:316–321. https://doi.org/10.1038/nature13013.
   PubMed Web of Science ®Google Scholar
• Baar MP, Perdiguero E, Muñoz-Cánoves P, de Keizer PL. 2018. Musculoskeletal senescence: a moving target ready to be eliminated. Curr Opin Pharmacol 40:147–155. https://doi.org/10.1016/j.coph.2018.05.007.
   PubMed Web of Science ®Google Scholar
• Valdez G, Tapia JC, Kang H, Clemenson GD, Jr, Gage FH, Lichtman JW, Sanes JR. 2010. Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc Natl Acad Sci U S A 107:14863–14868. https://doi.org/10.1073/pnas.1002220107.
   PubMed Web of Science ®Google Scholar
• Valdez G, Tapia JC, Lichtman JW, Fox MA, Sanes JR. 2012. Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One 7:e34640. https://doi.org/10.1371/journal.pone.0034640.
   PubMedGoogle Scholar
• Chai RJ, Vukovic J, Dunlop S, Grounds MD, Shavlakadze T. 2011. Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. PLoS One 6:e28090. https://doi.org/10.1371/journal.pone.0028090.
   PubMedGoogle Scholar
• White Z, White RB, McMahon C, Grounds MD, Shavlakadze T. 2016. High mTORC1 signaling is maintained, while protein degradation pathways are perturbed in old murine skeletal muscles in the fasted state. Int J Biochem Cell Biol 78:10–21. https://doi.org/10.1016/j.biocel.2016.06.012.
   PubMedGoogle Scholar
• Sakuma K, Kinoshita M, Ito Y, Aizawa M, Aoi W, Yamaguchi A. 2016. p62/SQSTM1 but not LC3 is accumulated in sarcopenic muscle of mice. J Cachexia Sarcopenia Muscle 7:204–212. https://doi.org/10.1002/jcsm.12045.
   PubMedGoogle Scholar
• Joseph A-M, Malamo AG, Silvestre J, Wawrzyniak N, Carey-Love S, Nguyen LMD, Dutta D, Xu J, Leeuwenburgh C, Adhihetty PJ. 2013. Short-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animals. Exp Gerontol 48:858–868. https://doi.org/10.1016/j.exger.2013.05.061.
   PubMedGoogle Scholar
• Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ. 2011. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331:456–461. https://doi.org/10.1126/science.1196371.
   PubMed Web of Science ®Google Scholar
• Bujak AL, Crane JD, Lally JS, Ford RJ, Kang SJ, Rebalka IA, Green AE, Kemp BE, Hawke TJ, Schertzer JD, Steinberg GR. 2015. AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging. Cell Metab 21:883–890. https://doi.org/10.1016/j.cmet.2015.05.016.
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10:307. https://doi.org/10.1038/nrm2672.
   PubMed Web of Science ®Google Scholar
• García-Prat L, Martínez-Vicente M, Perdiguero E, Ortet L, Rodríguez-Ubreva J, Rebollo E, Ruiz-Bonilla V, Gutarra S, Ballestar E, Serrano AL, Sandri M, Muñoz-Cánoves P. 2016. Autophagy maintains stemness by preventing senescence. Nature 529:37. https://doi.org/10.1038/nature16187.
   PubMed Web of Science ®Google Scholar